{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:05:04Z","timestamp":1773291904036,"version":"3.50.1"},"reference-count":96,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Discovery"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1517\/17460441.2011.586692","type":"journal-article","created":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T05:26:35Z","timestamp":1305955595000},"page":"827-837","source":"Crossref","is-referenced-by-count":4,"title":["Developments in the discovery of drugs for spinal muscular atrophy: successful beginnings and future prospects"],"prefix":"10.1517","volume":"6","author":[{"given":"Rebecca M.","family":"Pruss","sequence":"first","affiliation":[{"name":"Trophos, SA Parc Scientifique de Luminy Case 931, 13288 Marseille Cedex 9, France ; ;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,5,21]]},"reference":[{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90460-3"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1996.tb00725.x"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80367-0"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80368-2"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0797-265"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1086\/513913"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00125817-200201000-00004"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20473"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.11.6307"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/9.2.259"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1884910"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.171105098"},{"key":"e_1_3_1_15_1","unstructured":"China Medical College Hospital. US6573300; 2003"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20548"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddg256"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201102"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201320"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.160181697"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq094"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddm284"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1261\/rna.1273209"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq425"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq147"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/10.24.2841"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000208"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.26.4.1333-1346.2006"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0950-09.2009"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1941310"},{"key":"e_1_3_1_31_1","unstructured":"Available from: http:\/\/www.prosensa.eu\/technology-and-products\/pre-clinical-portfolio"},{"key":"e_1_3_1_32_1","unstructured":"Available from: http:\/\/www.isispharm.com\/Pipeline\/Therapeutic-Areas\/Neurodegenerative-Disease.htm#ISIS-SMNRx"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi205"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.10.228"},{"key":"e_1_3_1_35_1","unstructured":"Vertex Pharmaceuticals Inc. US7465738; 2008"},{"key":"e_1_3_1_36_1","unstructured":"Vertex Pharmaceuticals Inc. WO2004\/112205A2"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm061475p"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp510"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1021\/cb800120t"},{"key":"e_1_3_1_40_1","unstructured":"http:\/\/www.repligen.com\/products\/pipeline\/rgsma"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01262-08"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi131"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp030"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1021\/ol0269042"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp333"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2004.08.024"},{"key":"e_1_3_1_47_1","unstructured":"The Spinal Muscular Atrophy Project http:\/\/asent.org\/22308B47-E7FF-0F41-24C00CE1DE6EC4AC"},{"key":"e_1_3_1_48_1","unstructured":"The trustees of the University of Pennsylvania US2006\/0223092A1"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.06.004"},{"key":"e_1_3_1_50_1","unstructured":"Dreyfuss G Wan L US2010\/0234402A1"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-16-06627.2003"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200304128"},{"key":"e_1_3_1_53_1","first-page":"289","article-title":"Spinal muscular atrophy and a model for survival of motor neuron protein function in axonal ribonucleoprotein complexes","volume":"48","author":"Rossoll W","year":"2009","unstructured":"Rossoll W, Bassell GJ. Spinal muscular atrophy and a model for survival of motor neuron protein function in axonal ribonucleoprotein complexes. Results Probl Cell Differ 2009;48:289-326","journal-title":"Results Probl Cell Differ"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3631-10.2011"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/4.10.1927"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1155085"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq021"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq058"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature07677"},{"key":"e_1_3_1_60_1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1387\/ijdb.12141443","article-title":"Elucidating the molecular mechanisms that underlie the target control of motoneuron death","volume":"46","author":"Banks G","year":"2002","unstructured":"Banks G, Noakes PG. Elucidating the molecular mechanisms that underlie the target control of motoneuron death. Int J Dev Biol 2002;46:551-8","journal-title":"Int J Dev Biol"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi078"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddn156"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddm367"},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4434-08.2009"},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1610"},{"key":"e_1_3_1_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2010.01.006"},{"key":"e_1_3_1_67_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2208-10.2010"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2008.057950"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq329"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-7-14"},{"key":"e_1_3_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2008.05.014"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41615"},{"key":"e_1_3_1_73_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000830"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.21642"},{"key":"e_1_3_1_75_1","doi-asserted-by":"crossref","unstructured":"Lorson MA Spate LD Samuel MS Disruption of the Survival Motor Neuron (SMN) gene in pigs using ssDNA. Transgenic Res 2011. [Epub ahead of print]","DOI":"10.1007\/s11248-011-9496-8"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2010.114"},{"key":"e_1_3_1_77_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.123000"},{"key":"e_1_3_1_78_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph3020345"},{"key":"e_1_3_1_79_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2225-10.2011"},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2010.04.018"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000249142.82285.d6"},{"key":"e_1_3_1_82_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005268"},{"key":"e_1_3_1_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21838"},{"key":"e_1_3_1_84_1","unstructured":"Guidance for Industry Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination. Available from: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM236669.pdf"},{"key":"e_1_3_1_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301550"},{"key":"e_1_3_1_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.03868.x"},{"key":"e_1_3_1_87_1","first-page":"1492","article-title":"SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum. Mol","volume":"19","author":"Riessland M","year":"2010","unstructured":"Riessland M, Ackermann B, Forster A, SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum. Mol. Genet 2010;19:1492-1506","journal-title":"Genet"},{"key":"e_1_3_1_88_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29562"},{"key":"e_1_3_1_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-006-0186-1"},{"key":"e_1_3_1_90_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddn357"},{"key":"e_1_3_1_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp313"},{"key":"e_1_3_1_92_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2010.080366"},{"key":"e_1_3_1_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-006-0245-7"},{"key":"e_1_3_1_94_1","unstructured":"Whitehead Institute for Biomedical Research Trustees of Columbia University in the City of New York WO2006\/050451"},{"key":"e_1_3_1_95_1","unstructured":"Stockwell BR Root DE WO2009\/0031435"},{"key":"e_1_3_1_96_1","unstructured":"US Department of Health and Human Services Albany Molecular Research Saic US2009\/0312323A1"},{"key":"e_1_3_1_97_1","unstructured":"US Department of Health and Human Services Saic Albany Molecular Research US2010\/0267712A1"},{"key":"e_1_3_1_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-007-0441-0"}],"container-title":["Expert Opinion on Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/17460441.2011.586692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:44:37Z","timestamp":1770396277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/17460441.2011.586692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,21]]},"references-count":96,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.1517\/17460441.2011.586692"],"URL":"https:\/\/doi.org\/10.1517\/17460441.2011.586692","relation":{},"ISSN":["1746-0441","1746-045X"],"issn-type":[{"value":"1746-0441","type":"print"},{"value":"1746-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,21]]}}}